Literature DB >> 11016539

Vascular and parenchymal Abeta deposition in the aging dog: correlation with behavior.

F Crespeau, T Uchihara, H Akiyama, F Checler, P Pageat, C Duykaerts.   

Abstract

The behavior of 25 dogs was indirectly assessed by a formal questionnaire (evaluation of Age-Related Cognitive and Affective Disorders-ARCAD), filled out by the owner. The density of diffuse and vascular deposits was evaluated using four anti-Abeta peptide antibodies, in four temporal areas. Parenchymal, diffuse deposits of Abeta42 peptide were found in all aged animals but one. They were Congo red negative and were not immunostained by the anti-Abeta40 antibody, contrary to the vascular deposits. The densities of vascular and parenchymal deposits were not correlated. The ARCAD score was correlated with age, density of Abeta parenchymal and vascular deposits, and with the number of areas containing deposits (extension index). Multivariate analysis showed that the age and the extension index explained most of the variance. Congo red positivity (indicating that the Abeta peptide has the characteristics of an amyloid substance) is limited in the dog to the vascular wall and is associated, as in man, with the deposition of the Abeta 1-40 isoform. Parenchymal Abeta deposition seems to be a common correlate of behavioral problems in aging dogs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016539     DOI: 10.1016/s0197-4580(00)00113-5

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  28 in total

1.  Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.

Authors:  Eric Heuer; Jessica Jacobs; Rebecca Du; Silun Wang; Orion P Keifer; Amarallys F Cintron; Jeromy Dooyema; Yuguang Meng; Xiaodong Zhang; Lary C Walker
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine.

Authors:  Joseph A Araujo; Gary M Landsberg; Norton W Milgram; Alda Miolo
Journal:  Can Vet J       Date:  2008-04       Impact factor: 1.008

Review 3.  Aging in the canine and feline brain.

Authors:  Charles H Vite; Elizabeth Head
Journal:  Vet Clin North Am Small Anim Pract       Date:  2014-11-01       Impact factor: 2.093

Review 4.  Cognitive Aging in Dogs.

Authors:  Durga Chapagain; Friederike Range; Ludwig Huber; Zsófia Virányi
Journal:  Gerontology       Date:  2017-10-25       Impact factor: 5.140

5.  Neurobiology of the aging dog.

Authors:  Elizabeth Head
Journal:  Age (Dordr)       Date:  2010-09-16

Review 6.  A canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2013-03-23

7.  Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines.

Authors:  Lori-Ann Christie; Wycliffe O Opii; Elizabeth Head
Journal:  Age (Dordr)       Date:  2008-06-22

Review 8.  Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain aging.

Authors:  Elizabeth Head
Journal:  Neurochem Res       Date:  2008-08-06       Impact factor: 3.996

Review 9.  Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.

Authors:  Alex M Helman; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2015-12-17

10.  Natural non-trasgenic animal models for research in Alzheimer's disease.

Authors:  Manuel Sarasa; Pedro Pesini
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.